Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-06-12

Clinical Trial Update: Apremilast Treatment for Pruritus and Quality of Life in Scalp Psoriasis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on apremilast for pruritus and quality of life in scalp psoriasis; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OTEZLA (apremilast)

Snippet

Sponsor: University of Zurich | Conditions: Psoriasis of Scalp, Psoriasis Vulgaris | Phase 4 | Status: UNKNOWN